1 y present with vaginal bleeding, pain, and a pelvic mass.

2  for back pain to 19.46 (12.69 to 29.85) for pelvic mass.

3         Two years later, he developed a left pelvic mass.

4 inistered preoperatively to 128 women with a pelvic mass (84 benign and 44 malignant).

5 sical examination demonstrated a fixed, firm pelvic mass; a computed tomography-guided biopsy confirm

6  to suspect this syndrome in a female with a pelvic mass and absence of homolateral kidney.

7 tient (2%; 90% CI, < 1% to 10%) had a stable pelvic mass and substantial regression in an adrenal mas

8 a, prepubertal bleeding, primary amenorrhea, pelvic mass, and pelvic pain.

9  with other ovarian cancers, 166 with benign pelvic masses, and 142 healthy women.

10        Concurrently, his previously obtained pelvic mass biopsy sample was sent for panel-based genom

11 ecular biology, (ii) early-stage disease and pelvic mass in pregnancy, (iii) advanced stage (includin

12 nosis and to eliminate other etiologies like pelvic mass or thrombosis.

13  of the abdomen and pelvis showed an 11.6-cm pelvic mass, retroperitoneal lymphadenopathy, right hydr

14  thresholds to recommend which patients with pelvic masses should undergo evaluation by gynecologic o

15 performed at another hospital had revealed a pelvic mass; therefore, this patient had been referred t

16 e underwent palliative radiation to the left pelvic mass to relieve symptoms of pain and leg edema an

17 peritoneal lymphadenopathy and a large right pelvic mass with possible rectal wall invasion consisten